Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate ...

Changing a cultural undertow is one of the hardest leadership challenges in any industry, and perhaps even more so in the ...

EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic ...

While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by ...

A fourth revolution in cancer care is taking shape, one that steps away from the current well-trodden path. This revolution ...

Type of data available on UK Pharmascan registration, with a breakdown on whether the live record is for a new indication, ...

At ASCO 2025, ImmunityBio’s chief medical officer, Dr Sandeep Reddy, spoke with pharmaphorum about the importance of FDA ...

Describing the current treatment landscape for primary and secondary bone cancer, Romness explains the potential of their own ...